Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera BGI Genomics Remaining Performance Obligations by Quarter
BGI Genomics Remaining Performance Obligations — RPO ($M) [legacy through Q1 2025] ($M)
Natera BGI Genomics Remaining Performance Obligations: $6M in Q1 2025, unchanged from a year earlier. No newer figure appears in the documents we track.
Where the Q1 2025 figure comes from
Source: Form 10-Q (2025-05-09) ↗
Reported in Form 10-K/10-Q Note — Remaining Performance Obligations (2023–2025Q1).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | BGI Genomics Remaining Performance Obligations — RPO ($M) [legacy through Q1 2025] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2025 | Mar 31, 2025 | 6 | 0.0% | Form 10-Q (2025-05-09) ↗ |
| Q4 2024 | Dec 31, 2024 | 20 | +233.3% | Form 10-Q (2026-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 6 | – | Form 10-Q (2024-05-10) ↗ |
| Q4 2023 | Dec 31, 2023 | 6 | – | Form 10-K (2024-02-29) ↗ |
| Q3 2023 | Sep 30, 2023 | 6 | – | Form 10-Q (2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 6 | – | Form 10-Q (2023-08-04) ↗ |
Cite this data
StockData. (2026). Natera BGI Genomics Remaining Performance Obligations ($M), quarterly Q2 2023–Q1 2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rpo-bgi-total
See every metric in the Natera KPI table. Data updated Nov 2, 2026.